AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 163 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,268,000 | +19.8% | 50,000 | 0.0% | 0.13% | -4.4% |
| Q4 2016 | $1,893,000 | -87.7% | 50,000 | -87.7% | 0.14% | -86.4% |
| Q3 2016 | $15,352,000 | +182.2% | 406,771 | -63.7% | 0.99% | +69.7% |
| Q3 2014 | $5,441,000 | +29.7% | 1,121,951 | 0.0% | 0.58% | +41.7% |
| Q2 2014 | $4,196,000 | -6.4% | 1,121,951 | +430.4% | 0.41% | -12.5% |
| Q1 2014 | $4,482,000 | -16.8% | 211,518 | -29.5% | 0.47% | -27.2% |
| Q4 2013 | $5,388,000 | – | 300,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |